{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Morgantown",
      "state": "WV",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89357",
      "recalling_firm": "Mylan Pharmaceuticals Inc",
      "address_1": "3711 Collins Ferry Rd",
      "address_2": "N/A",
      "postal_code": "26505-2362",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA and Thailand.",
      "recall_number": "D-0462-2022",
      "product_description": "Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pen (NDC 49502-0196-71), packaged in Five 3 mL Prefilled Pens per carton (NDC 49502-0196-75), Rx only, Manufactured in Malaysia for: Mylan Specialty L.P., Morgantown, WV, 26505.",
      "product_quantity": "73,175 prefilled pens",
      "reason_for_recall": "Labeling: Missing Label: label missing from some Semglee prefilled pens.",
      "recall_initiation_date": "20220105",
      "center_classification_date": "20220128",
      "termination_date": "20240112",
      "report_date": "20220126",
      "code_info": "Batch # BF20003118, Exp. August 2022"
    }
  ]
}